New algorithm allows for faster, animal-free chemical toxicity testing

The use of animals to test the toxicity of chemicals may one day become outdated thanks to a low-cost, high-speed algorithm developed by researchers at Rutgers and other universities.

Toxicity testing — determining the amount of exposure to a chemical that is unsafe for humans — is vital to the safety of millions of workers in various industries. But of the 85,000 compounds used in consumer products, the majority have not been comprehensively tested for safety. Animal testing, in addition to its ethical concerns, can be too costly and time consuming to meet this need, according to the study published in Environmental Health Perspectives.

“There is an urgent, worldwide need for an accurate, cost-effective and rapid way to test the toxicity of chemicals, in order to ensure the safety of the people who work with them and of the environments in which they are used,” said lead researcher Daniel Russo, a doctoral candidate at the Rutgers University-Camden Center for Computational and Integrative Biology. “Animal testing alone cannot meet this need.”

Previous efforts to solve this problem used computers to compare untested chemicals with structurally similar compounds whose toxicity is already known. But those methods were unable to assess structurally unique chemicals — and were confounded by the fact that some structurally similar chemicals have very different levels of toxicity.

The Rutgers-led group overcame these challenges by developing a first-of-its-kind algorithm that automatically extracts data from PubChem, a National Institutes of Health database of information on millions of chemicals. The algorithm compares chemical fragments from tested compounds with those of untested compounds, and uses multiple mathematical methods to evaluate their similarities and differences in order to predict an untested chemical’s toxicity.

“The algorithm developed by Daniel and the Zhu laboratory mines massive amounts of data, and discerns relationships between fragments of compounds from different chemical classes, exponentially faster than a human could,” said co-author Lauren Aleksunes, an associate professor at Rutgers’ Ernest Mario School of Pharmacy and the Rutgers Environmental and Occupational Health Sciences Institute. “This model is efficient and provides companies and regulators with a tool to prioritize chemicals that may need more comprehensive testing in animals before use in commerce.”

To fine-tune the algorithm, the researchers began with 7,385 compounds for which toxicity data is known, and compared it with data on the same chemicals in PubChem. They then tested the algorithm with 600 new compounds. For several groups of chemicals, the Rutgers-led algorithm had a 62 percent to 100 percent success rate in predicting their level of oral toxicity. And by comparing relationships between sets of chemicals, they shed light on new factors that can determine the toxicity of a chemical.

Although the algorithm was directed only to assess the chemicals’ level of toxicity when consumed orally, the Rutgers-led researchers conclude that their strategy can be extended to predict other types of toxicity.

“While the complete replacement of animal testing is still not feasible, this model takes an important step toward meeting the needs of industry, in which new chemicals are constantly under development, and for environmental and ecological safety,” said the corresponding author Hao Zhu, an associate professor of chemistry at Rutgers-Camden and the Rutgers and Environmental and Occupational Health Sciences Institute.

Story Source:

Materials provided by Rutgers University. Note: Content may be edited for style and length.

Share Button

Want black women students to stay in STEM? Help them find role models who look like them

Representation matters for Black women college students when it comes to belonging in rigorous science, technology, engineering and mathematics (STEM) programs, according to a new study. Having role models who share their racial identity is vital to signaling a sense of belonging for women of color college students.

“Women who feel like they belong are more likely to enter and stay in STEM, so lack of belonging may be one reason for women of color’s lack of representation,” said Eva Pietri, Ph.D., second author on the paper and assistant professor of psychology at IUPUI.

While women of color college students report interest in STEM majors at an equivalent rate as White women students, they remain the least represented group in STEM. Women of color account for a small number of bachelor’s degrees across STEM fields with only 2.9% awarded to Black women, 3.6% to Latinas and 4.8% to Asian women in 2014-2015, according to the National Center for Education Statistics.

“Black and Latina women are among the most underrepresented groups in STEM, which means these disciplines are losing potentially talented workers, who can contribute important and new perspectives,” said India Johnson, PhD., first author on this paper, IUPUI alumna, and assistant professor of psychology at Elon University.

As women of color researchers, Johnson and Pietri found this issue personally relevant, and wanted to explore what environmental factors would predict a sense of belonging among Black women in STEM.

In their first study, researchers presented Black female students recruited from across the country with a fictional school of science and technology. The students, next, either viewed a profile for a professor who was either a Black female or Black male scientist or White female or White male scientist. Researchers found that the students anticipated more belonging and trust at the school when they saw that a Black man or woman scientist was working there opposed to a White woman or man scientist. The Black woman scientist, however, was particularly beneficial for Black female participants who were high in stigma consciousness — or those who are concerned about their gender and race being devalued in society.

“High levels of stigma consciousness related to less anticipated belonging and trust, unless Black female students saw a Black woman scientist at the school,” Pietri said. “This first study suggests that having role models who match their race and gender, or at least race, is beneficial for Black women student’s belonging.”

In a follow-up study, the researchers recruited Black women STEM majors at two very different universities. Specifically, they surveyed Black women STEM students from a predominately White four-year college and a women-only historically Black college. The two colleges were chosen to ensure there was variability in access to role models of different identities.

The researchers found that the women at the historically Black college had approximately two to three Black female role models, whereas the women enrolled at the primarily White institution had zero to one. Across both samples, the higher number of Black female and Black male role models the students had, the more belonging they felt at their institutions, again, highlighting the importance of access to Black men and Black women role models. At the same time, the researchers also found important implications for perceiving role models as allies and belonging in STEM.

“We found that having role models, who were not Black women, but who the STEM majors believed were allies related to higher belonging in STEM,” said Johnson.

Like Study 1, the researchers again found stigma consciousness had important implications for belonging. Higher stigma consciousness related to less belonging in STEM for women at the primarily White institution. However, for women at the historically Black institution, higher stigma consciousness did not harm belonging in STEM but instead correlated with more belonging at their institution.

“Under the right conditions, greater stigma consciousness might be beneficial,” Johnson said. “These results show that we don’t necessarily want to decrease it, but we want to create environments where it’s not detrimental. We find stigma consciousness can even be helpful when there are a lot of Black female role models and supportive allies available.”

Although increasing representation of women of color in STEM is the best way to improve belonging, the researchers hope to build tools to help white men or white women become better allies for women in STEM.

“Allies can play a really big role in increasing belonging among women of color, but they have to really clearly signal their allyship through actions and behaviors,” added Pietri.

Share Button

How inland waters ‘breathe’ carbon — and what it means for global systems

For a long time, scientists evaluating the global carbon cycle considered rivers and streams akin to pipes, channeling carbon and other solutes from the land to the sea. Today, however, scientists know that along the way these inland waters also “breathe” carbon and other gases into the atmosphere.

In fact, the critical role of this greenhouse gas “evasion” from rivers and streams was, for the first time, incorporated into the Fifth Assessment Report of the UN’s Intergovernmental Panel on Climate Change in 2014.

Yet much remains unknown about how much gas is actually released from these water systems and the chemical and ecological dynamics that affect their transport.

A new Yale study reveals important insights into the factors that influence the release of greenhouse gases from these inland waters, including a key relationship between storm events, ecology, and topography in moderating this release.

In an analysis of headwater streams in central Connecticut, scientists found that concentrations of three greenhouse gases — carbon dioxide, nitrous oxide, and methane — increased in wetland streams during rainstorms, but decreased or remained constant in forested streams. However, those gases were also less likely to be released from the wetland streams than from the streams in forested areas, they found.

Writing in the Journal of Geophysical Research: Biogeosciences, they conclude that these variances are likely due to the fact that forested streams tend to be steeper, creating greater turbulence that, in turn, promotes gas releases. Meanwhile, in wetland streams those inputs were more likely to be carried downstream farther from their source, said Kelly Aho, a doctoral candidate at the Yale School of Forestry & Environmental Studies (F&ES) and lead author of the study.

“When you think about what a wetland looks like, it makes sense: wetlands are really flat, which is why water and organic matter may accumulate there,” Aho said. “As a result, during a rainstorm those wetlands and their soils are a source of greenhouse gases.”

“But,” she added, “gas concentrations represent only half the equation.”

The release of gases from rivers and streams also depends on the gas transfer velocity, or the rate at which gases move across the air-water boundary. A lack of turbulence tends to produce a lower gas transfer velocity and slower rates. So while greenhouse gas concentrations in wetland streams will increase suddenly during a rainstorm, those gases are more likely to remain trapped in the flatter, less turbulent streams until they encounter steeper terrain farther downstream.

Understanding these dynamics, Aho said, will be critical in order to develop more accurate carbon cycle projections and climate models — particularly as extreme weather events are projected to increase in the coming decades.

“If a researcher is looking at carbon sequestration from a local perspective, they might be just monitoring what goes in and out vertically within a plot of land,” she said. “But if that area includes a wetland stream, for instance, the gases are likely to flow away from the plot they’re looking at; the carbon may be released into the atmosphere outside of their point of view, so you may totally miss it. So it’s important to think about this idea of lateral transport.

“That’s why streams and rivers are so interesting,” she added. “They’re moving solutes across the landscape, so we have to take that into account.”

Share Button

Health24.com | Supplemental steroids, testosterone may lower men’s sperm counts

Men who abuse hormones such as testosterone or steroids for bodybuilding can have declines in sperm and testosterone production, researchers say.

The good news: these changes seem to reverse once men stop hormone overuse.

Effect on men’s reproductive function

While the use of non-prescribed male hormones (androgens) has surged in many wealthy countries, there has been little research into their effect on men’s reproductive function, including sperm production, testosterone and fertility, according to lead researcher Nandini Shankara Narayana. She’s an endocrinologist at the University of Sydney and Concord Repatriation General Hospital in Australia.

The study of 93 men included 41 who were currently using testosterone or steroids; 31 who had used them three or more months before the study; and 21 healthy men who exercised regularly and did not use androgens.

Compared with men who had stopped using the hormones or who had never taken them, current users had significantly smaller testicles, on average, and lower sperm output, the study found.

Current users also had lower levels of luteinizing hormone, which is involved in testosterone production, and of follicle-stimulating hormone, which is involved in sperm production, the findings showed.

Little prognostic info available

Former users did not differ from men who had never taken the supplements in terms of sperm production and hormone levels, indicating complete recovery, according to the study presented Monday at the Endocrine Society’s annual meeting, in New Orleans.

On average, luteinizing hormone levels recovered within nine months after men stopped taking the supplements. Sperm output returned to normal in about 14 months and follicle-stimulating hormone levels normalized in nearly 19 months, the findings showed.

“These results will help endocrinologists involved in care of men who are using typically non-prescribed, high doses of androgens for bodybuilding, a practice that is increasingly recognised but for which virtually no prognostic information has been available to support medical care during recovery from androgen abuse,” Shankara Narayana said in an Endocrine Society news release.

Research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | Type 1 diabetics often unaware of low blood sugar episodes

When you have type 1 diabetes, keeping track of your blood sugar levels can be challenging. But new research suggests that seniors might really have trouble avoiding low blood sugar, or hypoglycaemia.

In fact, many patients over age 60 may experience up to 100 minutes of a day with low blood sugar and not even know it, the study researchers said.

Hypoglycaemia takes its toll

The bottom line: “Older adults with type 1 diabetes do spend a considerable amount of time in hypoglycaemia,” said study author Dr Anders Carlson. He’s medical director of the International Diabetes Center in Minneapolis.

“Hypoglycaemia can lead to a lot of severe consequences – loss of consciousness, accidents, falls, hospitalisations and ER visits. Older adults have a higher risk from hypoglycaemia in terms of arrhythmia [irregular heartbeat] that can result in higher cardiovascular problems,” Carlson explained.

“Hypoglycaemia can take a toll on people. You have to be ready and able to treat hypoglycaemia at any given moment,” he added.

Any blood sugar reading below 70 milligrams per decilitre (mg/dL) is considered low blood sugar. When blood sugar drops below 54 mg/dL, you’re at risk for more serious symptoms.

As blood sugar levels dip, you begin to experience symptoms such as shaking, sweating, headache, hunger, fatigue and blurred vision. As blood sugar drops lower, you may feel weak and have trouble concentrating. You may be confused or have changes in your personality. Eventually, untreated low blood sugar can lead to seizures, unconsciousness and even death, according to the US National Institute of Diabetes and Digestive and Kidney Diseases.

Uncomfortable warning symptoms

People who’ve had diabetes for a long time or who have had repeated low blood sugar are at risk of developing hypoglycaemia unawareness. These people no longer feel the uncomfortable warning symptoms of hypoglycaemia, according to the American Diabetes Association (ADA). This puts them at even greater risk of experiencing serious low blood sugar.

The study looked at 203 adults older than 60 who had type 1 diabetes. More than 90% were white, and just over half wore an insulin pump. Their overall diabetes management averaged within the range recommended for older adults by the ADA.

The participants wore a “blinded” continuous glucose monitor (CGM) for three weeks. Using an extremely thin sensor inserted underneath the skin, CGMs normally provide nearly constant access to blood sugar readings for the patient. The study devices, however, only gave that information to the researchers.

The study found that the volunteers spent an average of 72 minutes a day with blood sugar levels of less than 70 mg/dL and 24 minutes a day at less than 54 mg/dL. Those with hypoglycaemia unawareness spent even more time with low blood sugar levels.

The researchers didn’t notice a difference between day and night readings of low blood sugar.

A wake-up call

Dr Joel Zonszein is director of Montefiore Medical Center’s Clinical Diabetes Center in New York City, and was not involved with the research. “I’m not surprised by the study. This is what we see all the time now that CGM is becoming more available,” he noted.

Zonszein said older people don’t have the same counter-regulatory responses from the body that younger people do. That usually means that management of diabetes in older people should be less aggressive, he said.

“Frequent low blood sugars should be a wake-up call to rearrange the diabetes regimen,” he said.

Carlson agreed that it was important for treatment to try to minimise hypoglycaemia.

Carlson presented the findings at the Endocrine Society annual meeting, in New Orleans. Research presented at meetings is typically viewed as preliminary until it has been published in a peer-reviewed journal.

Image credit: iStock

Share Button

Health24.com | Immune-targeted treatment might help prevent peanut allergy crises

Allergic reactions to peanuts can be incredibly dangerous, causing the throat to close, the chest to tighten, and throw a person into life-threatening anaphylactic shock.

But researchers now believe they’ve found a way to head off that immune reaction by blocking the antibodies that cause it.

Inhibitors will block antibodies

There appear to be two specific allergens in peanut proteins that produce the most violent reaction from the immune system, according to the study.

A medication created to block the immune system from recognising those allergens appeared to eliminate allergic reaction to peanuts in laboratory blood tests, researchers reported.

“Antibodies will interact with our inhibitors, and our inhibitors will not trigger the allergic reaction, it will just block the antibodies,” explained senior researcher Basar Bilgicer. He’s an associate professor of chemical and biomolecular engineering with the University of Notre Dame in Indiana.

It has yet to be tested in human clinical trials, but the drug could be a step up from medications like the EpiPen and antihistamines, which only subdue symptoms once the reaction has started, Bilgicer said.

Food allergies occur when a person’s immune system recognises the food as a potential threat to the body and overreacts in response.

Science has started to examine how immune antibodies interact with food to produce these reactions, Bilgicer explained.

Very specific medication

In this case, Bilgicer and his research team took blood from 16 patients who are allergic to peanuts and started testing their antibodies to find which peanut allergens create the worst immune response.

The researchers identified two allergens that appear to be the main culprits, and then created a drug that would attach to the parts of a person’s allergy-specific antibodies that interact with peanuts.

The new medication blocked allergic response in the blood of 14 of the 16 patients, researchers reported.

“It’s very specific and only blocks those antibodies that are responsible for the allergic reaction,” Bilgicer said. “It doesn’t interfere with any other immune system responses.”

The drug they’ve created could wind up as a pill or monthly injection people would take to ward off their peanut allergy, Bilgicer said.

It also could be used to help patients receiving immunotherapy, which involves exposing them to small amounts of peanuts to gradually reduce their immune response.

“Some patients are so allergic they are not eligible for undergoing immunotherapy,” Bilgicer said. “Potentially, this could be used in combination with immunotherapy to desensitise those patients and get rid of the allergic condition for good.”

The study was published in Proceedings of the National Academy of Sciences.

Allergy experts called the new research “exciting”.

‘Wait and see’

“Something like this, which seems to be going to where the problem occurs at the level of the recognition of the allergen, is an exciting thing,” said Dr Punita Ponda. She’s assistant chief of allergy and immunology at Northwell Health in Great Neck, New York.

But right now this has only been tested in the lab, and Ponda said the complexity of the human immune system could create unpredictable problems in clinical trials.

For example, the immune system contains many redundancies, so blocking these specific immune receptors might cause the immune system to become more sensitive to other antigens in peanuts, Ponda said.

“We have to wait and see,” Ponda said. “I think what I’m saying is, it’s exciting but let’s not count our chickens before they’re hatched.”

Dr Edwin Kim, an assistant professor of medicine with the University of North Carolina, said he’s curious how this approach might be used to help people with multiple food allergies.

He’s also interested in how the immune system would respond to such a therapy long-term.

“Say you can successfully treat for a year,” Kim said. “Is there some sort of feedback mechanism or something that tells the immune system, OK, look, nothing’s happening, you can dial yourself down, and get a lasting effect that way? That would be pretty exciting to see.”

Bilgicer said his team is now looking for funding that would allow them to pursue clinical trials.

Image credit: iStock

Share Button

Artificial gravity tests could reduce muscle loss, say researchers

Spinning bedridden patients and astronauts on a centrifuge could maintain muscle strength, scientists say.

Share Button

Epilepsy charity calls for social media seizure warnings

People with epilepsy are being exposed to flashing images, some deliberately, says a charity.

Share Button

Clampdown planned for British online pharmacies

New rules should help keep patients safe, says the General Pharmaceutical Council.

Share Button

Sleep myths ‘damaging your health’

US researchers have looked at the most common ones that we may fall for.

Share Button